Invention Grant
- Patent Title: Hydantoin derivatives as Kv3 inhibitors
-
Application No.: US14403011Application Date: 2013-05-22
-
Publication No.: US09669030B2Publication Date: 2017-06-06
- Inventor: Charles Large
- Applicant: AUTIFONY THERAPEUTICS LIMITED
- Applicant Address: GB London
- Assignee: AUTIFONY THERAPEUTICS LIMITED
- Current Assignee: AUTIFONY THERAPEUTICS LIMITED
- Current Assignee Address: GB London
- Agency: Nixon & Vanderhye P.C.
- Priority: GB1209013.0 20120522; GB1209986.7 20120606; GB1222528.0 20121213
- International Application: PCT/GB2013/051343 WO 20130522
- International Announcement: WO2013/175211 WO 20131128
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D405/14 ; C07D307/94 ; C07D311/76 ; C07D401/04 ; C07D403/04 ; C07D405/12 ; C07D307/87 ; A61K31/4439
Abstract:
The present invention relates to the prophylaxis of acute noise-induced hearing loss by administering a compound of formula (I): wherein: W is group (Wa), group (Wb) or group (Wc):
Public/Granted literature
- US20150157631A1 HYDANTOIN DERIVATIVES AS KV3 INHIBITORS Public/Granted day:2015-06-11
Information query
IPC分类:
